NCT05191511

Brief Summary

Abstract The equipment "infrared therapeutic device" is widely used in various medical institutions in Taiwan. The infrared therapeutic device improves the blood circulation, relieves muscle stiffness and pain by the heat energy radiated by the infrared light, and has a significant relief effect on patients with joint pain, muscle soreness, and back discomfort. However, the principle of the infrared therapeutic device is thermal energy, and there is no complete literature on the parameters such as treatment intensity and time and the full distance. In addition, the literature on the damage that can be caused is not based on clinical evidence, and there is no standardization study on the use of equipment, so it is hoped that this test will explore the safety distance of infrared therapeutic devices. The project is expected to recruit 50 people from 20 years old to 75 years old in the Chinese Medicine Clinic of Tainan Hospital of the Ministry of Health and Welfare, which is included in the diagnosis of osteoarthritis, degenerative arthritis, osteoporosis and other related Chinese medicine clinics. In patients with diseases, the main complaint must include patients with lower back pain and back pain. Subjects should exclude diseases that may be affected by chemoradiotherapy, cardiovascular disease, anemia, hypertension, etc., and exclude dermatitis, skin irritation, and erythema. Skin diseases such as lupus. The test site is the TCM clinic of Tainan Hospital of the Ministry of Health and Welfare. The air conditioner is fixed at a constant temperature of 28 degrees. The output power is calculated by the wattage meter, and the distance and temperature of the infrared lamp are measured. Finally, the appropriate temperature and distance of the infrared lamp to the human skin are estimated through calculation. Keywords: Infrared, Far- infrared, Burn

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 4, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 4, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

October 4, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 13, 2022

Completed
Last Updated

January 13, 2022

Status Verified

September 1, 2021

Enrollment Period

8 months

First QC Date

October 4, 2021

Last Update Submit

January 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Body temperature of skin surface

    Local body temperature of skin surface

    15 minutes

Secondary Outcomes (1)

  • Distance from IR lamp to skin

    15 minutes

Interventions

Far- infraredRADIATION

safety of far- infrared

Eligibility Criteria

Age20 Years - 89 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Recruitment of the Department of Traditional Chinese Medicine, Tainan Hospital, Ministry of Health and Welfare

You may qualify if:

  • Healthy adults over the age of 20 are not excluded from patients with lower back pain.

You may not qualify if:

  • Exclude cardiovascular diseases, anemia, high blood pressure and other diseases that may affect circulation.
  • People with skin diseases, skin allergies, and skin abnormalities.
  • Patients who are clinically diagnosed with cancer or other major injuries.
  • Excluded conditions are alcoholics, diabetic patients (blood sugar greater than or equal to 200 mg/dL), and severe or life-threatening complications (determined by the trial host based on medical history).
  • Women who are pregnant or breastfeeding (positive urine pregnancy test).
  • The moderator decides that it is not suitable to participate in this research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tainan Hospital, Ministry of Health and Welfare

Tainan, West Central Dist, 70043, Taiwan

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 4, 2021

First Posted

January 13, 2022

Study Start

March 4, 2019

Primary Completion

November 4, 2019

Study Completion

December 31, 2019

Last Updated

January 13, 2022

Record last verified: 2021-09

Locations